周邊動脈疾病(PAD) 市場規模、佔有率和成長分析：按類型、按治療類型、按疾病、按給藥途徑、按最終用戶、按地區 - 行業預測，2024-2031 年

2022年周邊動脈疾病（PAD）市場規模為42.7億美元，從2023年的46.6億美元成長到2031年的92.8億美元，預計複合年成長率為2024年至2031年。

根據研究，美國40歲以上的人中約有650萬人患有周邊動脈疾病（PAD）。儘管男性和女性都易感，但統計數據顯示，非裔美國人患這種疾病的風險更高。隨著老齡化，血管疾病變得更加常見，老化顯著導致周邊動脈疾病（PAD）盛行率的增加。此外，人口老化的加劇與 PAD 診斷、管理和治療相關產品的核准增加有關。這些因素共同增加了罹患周邊動脈疾病(PAD) 的整體風險。人口變化、疾病盛行率上升和醫療技術進步的綜合作用凸顯了美國與 PAD 相關的危險因子的複雜性。

目錄

介紹

• 這項研究的目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 技術分析
• 價值鏈分析
• 價格分析
• Start-Ups分析
• 監管環境
• 專利分析
• 管道分析
• 成功的關鍵因素
• 市場吸引力指數
• 競爭程度
• 主要投資機會
• 生態系繪圖

周邊動脈疾病（PAD）市場：按類型

• 市場概況
• 周圍血管成形術用氣球
• 斑塊修飾裝置
• 外周支架
• 周邊導管
• 血流動力學血流調節裝置
• 下腔靜脈濾器
• 周邊設備配件

周邊動脈疾病(PAD) 市場：依治療類型

• 市場概況
• 裝置
• 導管
• 藥品
• 斑塊修飾裝置
• 血流動力學血流調節裝置
• 其他

周邊動脈疾病（PAD）市場：依疾病分類

• 市場概況
• 降血脂藥
• 三氫療法
• 血糖值調節器
• 預防血栓藥物
• 強心藥
• 溶栓劑
• 發炎劑

周邊動脈疾病(PAD) 市場：依途徑

• 市場概況
• 口服
• 胃腸外的
• 其他

周邊動脈疾病(PAD) 市場：依最終用戶分類

• 市場概況
• 醫院/診所
• 門診手術診所

周邊動脈疾病(PAD) 市場：按地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• Bayer AG（Germany）
• Abbott Laboratories（USA）
• Medtronic（USA）
• Boston Scientific（USA）
• Cook Medical（USA）
• Terumo Corporation（Japan）
• CR Bard（USA）
• Cardinal Health（USA）
• Becton, Dickinson and Company（BD）（USA）
• AngioDynamics（USA）
• Philips Healthcare（Netherlands）
• Biotronik（Germany）
• Straub Medical（Switzerland）
• WL Gore & Associates（USA）
• Endologix（USA）
• Merit Medical Systems（USA）
• Kawasumi Laboratories（Japan）
• Biosensors International（Singapore）
• iVascular（Spain）
• Lepu Medical（China）
• OptiMed（Germany）

Peripheral Artery Disease Market size was valued at USD 4.27 billion in 2022 and is poised to grow from USD 4.66 billion in 2023 to USD 9.28 billion by 2031, growing at a CAGR of 9.80% in the forecast period (2024-2031).

Surveys indicate that around 6.5 million individuals aged 40 and above in the United States are affected by Peripheral Artery Disease (PAD). Both men and women are susceptible, but statistics indicate that African Americans face a higher risk of developing this condition. The aging population significantly contributes to the increasing prevalence of PAD, as vascular diseases become more common with age. Moreover, the ongoing aging of the population correlates with an increase in approvals for products related to the diagnosis, management, and treatment of PAD. Together, these factors heighten the overall risk of developing peripheral arterial disease. The convergence of demographic changes, rising disease prevalence, and advancements in medical technology highlights the complex nature of the risk factors associated with PAD in the United States.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Artery Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Artery Disease Market Segmental Analysis

The peripheral artery disease market is segmented into product type, route of administration, end user, and region. Based on product type, the market is segmented into Peripheral Angioplasty Balloons, Plaque Modification Devices, Peripheral Stents, Peripheral Catheters, Hemodynamic Flow Alteration Devices, Inferior Vena Cava Filters, Peripheral Accessories. Based on the route of administration, the peripheral artery disease market is segmented into oral, parenteral, and others. Based on end users, the peripheral artery disease market is segmented into hospitals & clinics, ambulatory surgical clinics, and others. Based on region, the market is segmented into North America, Asia Pacific, Europe, Middle East & Africa, and Latin America.

Drivers of the Peripheral Artery Disease Market

The increasing prevalence of diabetes and hypertension among elderly populations is a notable risk factor driving the rise in peripheral artery disease (PAD), thereby boosting market demand. Elderly individuals are particularly vulnerable to developing vascular complications, with diabetes and hypertension significantly heightening this risk. These chronic conditions frequently result in the narrowing and hardening of arteries, reducing blood flow to the extremities and escalating the probability of PAD.

Restraints in the Peripheral Artery Disease Market

The expected recurrence of peripheral artery disease (PAD) following treatment is anticipated to present a significant hurdle to the growth of the peripheral arterial disease market in the forecast period. Despite advancements in medical interventions, the possibility of PAD recurring poses a challenge to sustained market expansion. Moreover, concerns about product recalls within the industry could exacerbate difficulties for the peripheral arterial disease market in the near term. Product recalls have the potential to impact consumer confidence, attract regulatory scrutiny, and necessitate corrective actions, all of which may hinder overall growth and stability in the PAD market. Addressing these challenges will require collaborative efforts from stakeholders to navigate the complexities of disease management and ensure the ongoing development of effective solutions in the realm of peripheral arterial disease.

Market Trends of the Peripheral Artery Disease Market

The rising prevalence of peripheral artery diseases (PAD) alongside increasing approvals of new products are key factors projected to create opportunities for growth in the PAD market in the coming years. The growing incidence of PAD, which involves the narrowing of arteries supplying blood to the limbs, underscores the urgent requirement for advanced diagnostic and treatment options. With regulatory bodies consistently approving new products designed to tackle the complexities associated with PAD, the market is set to expand. These approvals signify advancements in medical technology, introducing innovative approaches to diagnose, manage, and treat PAD effectively.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Peripheral Artery Disease Market by Type

• Market Overview
• Peripheral Angioplasty Balloons
• Plaque Modification Devices
• Peripheral Stents
• Peripheral Catheters
• Hemodynamic Flow Alteration Devices
• Inferior Vena Cava Filters
• Peripheral Accessories

Peripheral Artery Disease Market by Treatment Type

• Market Overview
• Devices
• Catheters
• Drugs
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Other

Peripheral Artery Disease Market by Disease

• Market Overview
• Lipid Lowering Drugs
• Triple-H Therapy
• Glucose Regulating Drugs
• Blood Clot Preventing Drugs
• Inotropes
• Thrombolytic Agents
• Anti-Inflammatory Agents

Peripheral Artery Disease Market by Route of Administration

• Market Overview
• Oral
• Parenteral
• Others

Peripheral Artery Disease Market by End Users

• Market Overview
• Hospitals & Clinics
• Ambulatory Surgical Clinics

Peripheral Artery Disease Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C. R. Bard (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Straub Medical (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kawasumi Laboratories (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosensors International (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iVascular (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptiMed (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments